Table 1. Demographic Characteristics for the Cohorts of RZV and ZVL Vaccinees Included in the Analysisa.
| Characteristic | No. (%) | |
|---|---|---|
| RZV (Oct 1, 2017-Dec 31, 2018) | ZVL (Oct 1, 2012-Sep 30, 2017) | |
| Total | 849 397 (100) | 1 817 099 (100) |
| Age (categories)b | ||
| 65-69 | 199 113 (23.44) | 532 652 (29.31) |
| 70-74 | 261 960 (30.84) | 525 539 (28.92) |
| 75-79 | 197 831 (23.29) | 360 392 (19.83) |
| 80-84 | 113 180 (13.32) | 227 336 (12.51) |
| 85-89 | 55 685 (6.56) | 125 642 (6.91) |
| ≥90 | 21 628 (2.55) | 45 538 (2.51) |
| Sex | ||
| Male | 353 126 (41.57) | 730 515 (40.20) |
| Female | 496 271 (58.43) | 1 086 584 (59.80) |
| Race | ||
| Asian | 23 497 (2.77) | 62 222 (3.42) |
| Black | 18 631 (2.19) | 69 489 (3.82) |
| Hispanic | 6135 (0.72) | 26 557 (1.46) |
| White | 757 480 (89.18) | 1 599 453 (88.02) |
| Unknown/other | 43 654 (5.14) | 59 378 (3.27) |
Abbreviations: RZV, recombinant zoster vaccine; ZVL, zoster vaccine live.
a
Column totals may add up to 99.9% due to rounding.
b
Age at the first eligible vaccination.